Evaluation of the analytical and clinical performance of the Elecsys® CA 15-3 immunoassay

Clinical Chemistry

Volumn 47, Issue 12, 2001, Pages 2162-2164

  Stieber, P ^a   Molina, R ^a   Chan, D W ^a   Fritsche, H A ^a   Beyrau, R ^a   Bonfrer, J M G ^a   Filella, X ^a   Gornet, T G ^a   Hoff, T ^a   Jager W ^a   Van Kamp, G J ^a   Nagel, D ^a   Peisker, K ^a   Sokoll, L J ^a   Troalen, F ^a   Untch, M ^a   Domke, I ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CA 15-3 ANTIGEN;

ANALYTIC METHOD; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EVALUATION; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; PERFORMANCE;

EID: 0035204766     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/47.12.2162     Document Type: Article

References (12)

1. CA 15-3
2. Analytical and clinical evaluation of an electrochemiluminescence immunoassay for the determination of CA 125
3. Guidelines for the evaluation of analysers in clinical chemistry
4. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I
5. Range of linearity
6. Graphical comparisons of interferences in clinical chemistry instrumentation
7. Quality control and standardization of tumor marker tests
8. The meaning and use of the area under a receiver operating characteristics curve
9. The early detection of disseminated (metastasized) breast cancer by serial tumour marker measurements
10. CA 15-3 in the prediction of recurrence of breast cancer
11. Objective measurement of therapeutic response in breast cancer using tumor markers